Reference SummaryFesting MFW, Mouse Genome 1996;94(3):523-677
Title |
Inbred Strains of Mice (Updated July 30, 1996) | ||||||||||||||||||||||||||||||||||||||||||||||||
Authors |
Festing MFW | ||||||||||||||||||||||||||||||||||||||||||||||||
Journal |
Mouse Genome | ||||||||||||||||||||||||||||||||||||||||||||||||
Volume |
94 | ||||||||||||||||||||||||||||||||||||||||||||||||
Issue |
3 | ||||||||||||||||||||||||||||||||||||||||||||||||
Year |
1996 | ||||||||||||||||||||||||||||||||||||||||||||||||
Pages |
523-677 | ||||||||||||||||||||||||||||||||||||||||||||||||
Abstract |
|||||||||||||||||||||||||||||||||||||||||||||||||
Links |
J:97121 – MGI References |
||||||||||||||||||||||||||||||||||||||||||||||||
Strain Notes
|
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
CE | Adrenal gland - Cortex tumor |
|
Adrenal gland - Cortex |
high |
|
FVB | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
observed |
||
NH | Adrenal gland adenoma | Adrenal gland |
10 |
||
NH | Adrenal gland adenoma |
|
Adrenal gland |
10 |
|
NH | Adrenal gland hyperplasia - nodular | Adrenal gland |
10 |
||
BALB/c | Blood vessel hemangioendothelioma |
|
Blood vessel |
high |
|
HR/De | Blood vessel hemangioendothelioma | Blood vessel |
19.0 - 33.0 |
||
HR/De | Blood vessel hemangioendothelioma |
|
Blood vessel |
54.0 - 76.0 |
|
VM | CNS - Brain - Astrocyte astrocytoma | CNS - Brain - Astrocyte |
1.5 |
||
IF | CNS - Brain tumor |
|
CNS - Brain |
observed |
|
AB | Connective tissue - Fibroblast fibrosarcoma | Connective tissue - Fibroblast |
15.0 - 30.0 |
||
C57BL | Connective tissue - Fibroblast fibrosarcoma |
|
Connective tissue - Fibroblast |
observed |
|
CHI | Connective tissue - Fibroblast fibrosarcoma |
|
Connective tissue - Fibroblast |
observed |
|
BALB/c | Connective tissue - Synovium synovioma | Connective tissue - Synovium |
2.0 - 8.0 |
||
NZY | Connective tissue tumor |
|
Connective tissue |
high |
|
FVB | Eye - Harderian gland adenoma | Eye - Harderian gland |
observed |
||
C3H | Eye - Harderian gland tumor | Eye - Harderian gland |
observed |
||
SJL | Eye - Retina hyperplasia | Eye - Retina |
high |
||
SJL | Eye - Retina tumor | Eye - Retina |
high |
||
TM | Forestomach papilloma | Forestomach |
27 |
||
(C3H x MSM)F1 | Forestomach squamous cell carcinoma |
|
Forestomach |
observed |
|
TM | Heart tumor | Heart |
low |
||
P/J | Intestine - Large Intestine - Colon tumor |
|
Intestine - Large Intestine - Colon |
observed |
|
SWR | Intestine - Large Intestine - Colon tumor |
|
Intestine - Large Intestine - Colon |
observed |
|
DBA/2 | Intestine - Small Intestine - Duodenum polyp | Intestine - Small Intestine - Duodenum |
moderate |
||
NZO | Intestine - Small Intestine - Duodenum tumor | Intestine - Small Intestine - Duodenum |
high |
||
BALB/c | Kidney tumor | Kidney |
25.0 - 48.0 |
||
BALB/c | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell plasmacytoma |
|
Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell |
observed |
|
NZB | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell plasmacytoma |
|
Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell |
observed |
|
AKR-Fv1b | Leukocyte - Lymphocyte - B-lymphocyte leukemia | Leukocyte - Lymphocyte - B-lymphocyte |
28 |
||
SL/Kh | Leukocyte - Lymphocyte - B-lymphocyte lymphoma | Leukocyte - Lymphocyte - B-lymphocyte |
observed |
||
AKR-Fv1b | Leukocyte - Lymphocyte - T-lymphocyte leukemia | Leukocyte - Lymphocyte - T-lymphocyte |
7 |
||
A/He | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
0 |
||
A/J | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
1 |
||
A | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
10.0 - 43.0 |
||
AKR | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
4 - 87.0 |
||
BALB/c | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
0 |
||
C3H/Fg | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
90 |
||
C3H | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
0 |
||
C57BL/6 | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
2 |
||
C57BR/cd | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
1 |
||
C57L | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
1 - 4 |
||
DBA/1 | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
1 |
||
DBA/2 | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
0 - 3 |
||
MA | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
0 - 1 |
||
NZW | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
3.0 - 29.0 |
||
P/J | Leukocyte - Lymphocyte leukemia - lymphocytic | Leukocyte - Lymphocyte |
22 - 58 |
||
RFM | Leukocyte - Lymphocyte leukemia - lymphocytic |
|
Leukocyte - Lymphocyte |
high |
|
SJL | Leukocyte - Lymphocyte leukemia - lymphocytic |
|
Leukocyte - Lymphocyte |
observed |
|
BALB/c | Leukocyte - Lymphocyte lymphoma - small lymphocytic | Leukocyte - Lymphocyte |
5 |
||
C57BL/HeDe | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
75 |
||
C57BL/Ka | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
29 |
||
C57L | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
25 - 55 |
||
DBA/2 | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
18 |
||
HR/De Hrhr/+ | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
12 |
||
HR/De Hrhr | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
8 |
||
SJL | Leukocyte - Lymphocyte reticulum cell neoplasm, type B | Leukocyte - Lymphocyte |
observed |
||
FVB | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
observed |
||
SJL | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
observed |
||
BXH2/TyJ | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) |
observed |
||
L2 | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) |
observed |
||
RFM | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic |
|
Leukocyte - Myelocyte (Granulocyte) |
high |
|
RFM | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic | Leukocyte - Myelocyte (Granulocyte) |
observed |
||
SJL | Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic |
|
Leukocyte - Myelocyte (Granulocyte) |
observed |
|
A/HeJ | Leukocyte leukemia | Leukocyte |
3 |
||
A | Leukocyte leukemia |
|
Leukocyte |
observed |
|
AB | Leukocyte leukemia | Leukocyte |
35.0 - 54.0 |
||
ACR/A | Leukocyte leukemia | Leukocyte |
10.0 - 36.0 |
||
AKR | Leukocyte leukemia | Leukocyte |
70.0 - 90.0 |
||
BALB/c | Leukocyte leukemia | Leukocyte |
5 |
||
BALB/c | Leukocyte leukemia |
|
Leukocyte |
observed |
|
BALB/c | Leukocyte leukemia |
|
Leukocyte |
observed |
|
BN/a | Leukocyte leukemia | Leukocyte |
7.1 |
||
BN/b | Leukocyte leukemia | Leukocyte |
1.8 |
||
BOB | Leukocyte leukemia |
|
Leukocyte |
observed |
|
C3H/Bi | Leukocyte leukemia | Leukocyte |
low |
||
C57BL/6 | Leukocyte leukemia | Leukocyte |
7 |
||
C57BLKS/J | Leukocyte leukemia |
|
Leukocyte |
high |
|
C58 | Leukocyte leukemia | Leukocyte |
97 |
||
CBA | Leukocyte leukemia | Leukocyte |
4.0 - 10.0 |
||
CBA | Leukocyte leukemia |
|
Leukocyte |
observed |
|
DBAf/A | Leukocyte leukemia | Leukocyte |
5.0 - 8.0 |
||
DBA/LiA | Leukocyte leukemia | Leukocyte |
0 |
||
DBA/2 | Leukocyte leukemia | Leukocyte |
3 |
||
DBA/2 | Leukocyte leukemia |
|
Leukocyte |
high |
|
F/St | Leukocyte leukemia | Leukocyte |
high |
||
HRS Hrhr | Leukocyte leukemia | Leukocyte |
45 - 70 |
||
HRS Hrhr/+ | Leukocyte leukemia | Leukocyte |
1 - 20 |
||
PL | Leukocyte leukemia | Leukocyte |
19 - 90.0 |
||
RF | Leukocyte leukemia | Leukocyte |
46 - 66 |
||
RFM | Leukocyte leukemia | Leukocyte |
5 |
||
SJL | Leukocyte leukemia | Leukocyte |
83 |
||
SJL | Leukocyte leukemia |
|
Leukocyte |
high |
|
SL | Leukocyte leukemia | Leukocyte |
high |
||
SL/Ms | Leukocyte leukemia | Leukocyte |
low |
||
T739 | Leukocyte leukemia | Leukocyte |
1.3 |
||
XVII | Leukocyte leukemia | Leukocyte |
0 - 1.6 |
||
XVII | Leukocyte leukemia |
|
Leukocyte |
observed |
|
129 | Leukocyte lymphoma | Leukocyte |
2 - 7 |
||
C57BL/10 | Leukocyte lymphoma | Leukocyte |
29 - 31 |
||
C57BL/6 | Leukocyte lymphoma |
|
Leukocyte |
high |
|
CBA | Leukocyte lymphoma | Leukocyte |
6 - 15 |
||
CWD | Leukocyte lymphoma | Leukocyte |
observed |
||
DBA/2 | Leukocyte lymphoma | Leukocyte |
observed - 12 |
||
FVB | Leukocyte lymphoma | Leukocyte |
observed |
||
LP | Leukocyte lymphoma | Leukocyte |
1 - 8 |
||
NZO | Leukocyte lymphoma | Peyer's patch |
15.0 - 20.0 |
||
PBA | Leukocyte lymphoma | Leukocyte |
100 |
||
SAMP7 | Leukocyte lymphoma | Thymus |
43 |
||
SL/Am | Leukocyte lymphoma | Leukocyte |
high |
||
SL | Leukocyte lymphoma | Leukocyte |
48 - 100 |
||
FVB | Liver hepatocellular tumor | Liver |
observed |
||
VY Avy/a | Liver hepatocellular tumor | Liver |
24 |
||
VY a/a | Liver hepatocellular tumor | Liver |
13 |
||
C3H/Hef | Liver hepatoma | Liver |
high |
||
C3H | Liver hepatoma | Liver |
30.0 - 91.0 |
||
C57BR/cd | Liver hepatoma | Liver |
25 |
||
CBA | Liver hepatoma | Liver |
0 - 24 |
||
YS Ay/a | Liver hepatoma | Liver |
11 |
||
YS a/a | Liver hepatoma | Liver |
3 |
||
C3H | Liver tumor | Liver |
9.0 - 23.0 |
||
C57BR/cd | Liver tumor |
|
Liver |
very high |
|
C57BR/cd | Liver tumor |
|
Liver |
very high |
|
CBA | Liver tumor |
|
Liver |
observed |
|
CE | Liver tumor | Liver |
11.0 - 57.0 |
||
DBA/2 | Liver tumor | Liver |
6.0 - 35.0 |
||
OUF | Liver tumor | Liver |
observed |
||
A | Lung adenoma | Lung |
high |
||
A/BrA | Lung adenoma | Lung |
53.0 - 64.0 |
||
A/A | Lung adenoma | Lung |
53.0 - 64.0 |
||
ACR/A | Lung adenoma | Lung |
54.0 - 67.0 |
||
C3Hf/A | Lung adenoma | Lung |
2.0 - 10.0 |
||
C57BL/LiA | Lung adenoma | Lung |
0.0 - 9.0 |
||
CBA/BrA | Lung adenoma | Lung |
2.0 - 11.0 |
||
DBAf/A | Lung adenoma | Lung |
1.0 - 11.0 |
||
PBA | Lung adenoma | Lung |
77 |
||
T739 | Lung adenoma | Lung |
30 |
||
XVII | Lung adenoma | Lung |
19.5 |
||
129 | Lung tumor | Lung |
4.0 - 46.0 |
||
A/J | Lung tumor | Lung |
6 - 32 |
||
A/He | Lung tumor | Lung |
23 - 44 |
||
A | Lung tumor | Lung |
4.0 - 90 |
||
A | Lung tumor |
|
Lung |
observed |
|
A | Lung tumor |
|
Lung |
observed |
|
A2G | Lung tumor | Lung |
17.0 - 65.0 |
||
A2G | Lung tumor |
|
Lung |
observed |
|
AB | Lung tumor | Lung |
moderate |
||
AKR | Lung tumor | Lung |
1 |
||
BALB/cSc | Lung tumor | Lung |
14 - 32 |
||
BALB/c | Lung tumor | Lung |
10.0 - 29.0 |
||
BALB/c | Lung tumor |
|
Lung |
high |
|
BL | Lung tumor | Lung |
observed |
||
BN/a | Lung tumor | Lung |
35 |
||
BN/b | Lung tumor | Lung |
25 |
||
C3H | Lung tumor | Lung |
2.0 - 10.0 |
||
C57BL/6 | Lung tumor | Lung |
0 - 3 |
||
C57BL/6 | Lung tumor |
|
Lung |
observed |
|
C57BL/6 | Lung tumor |
|
Lung |
observed |
|
C57BR/cd | Lung tumor | Lung |
0 - 3 |
||
C57L | Lung tumor | Lung |
1 |
||
CC57BR | Lung tumor | Lung |
22 |
||
DBA/1 | Lung tumor | Lung |
0 - 27.0 |
||
DBA/2 | Lung tumor | Lung |
1 - 23.0 |
||
FVB | Lung tumor | Lung |
observed |
||
LIS | Lung tumor | Lung |
observed |
||
LP | Lung tumor | Lung |
4 - 5 |
||
MA | Lung tumor | Lung |
37 - 42 |
||
MAS | Lung tumor | Lung |
high |
||
NZO | Lung tumor | Lung |
high |
||
NZW | Lung tumor | Lung |
2.0 - 24.0 |
||
P/J | Lung tumor | Lung |
0 - 3 |
||
RFM | Lung tumor | Lung |
19 - 24 |
||
STS | Lung tumor | Lung |
observed |
||
SWR | Lung tumor | Lung |
36 - 80 |
||
TM | Lung tumor | Lung |
48 |
||
XVII | Lung tumor | Lung |
5.1 - 8.8 |
||
A/J | Mammary gland adenocarcinoma | Mammary gland |
0 - 28 |
||
A/He | Mammary gland adenocarcinoma | Mammary gland |
54 |
||
AKR | Mammary gland adenocarcinoma | Mammary gland |
1 |
||
BALB/c | Mammary gland adenocarcinoma | Mammary gland |
0 - 5 |
||
C3H | Mammary gland adenocarcinoma |
|
Mammary gland |
1.0 - 95 |
|
C57BL/6 | Mammary gland adenocarcinoma | Mammary gland |
1 |
||
C57L | Mammary gland adenocarcinoma | Mammary gland |
0 - 3 |
||
DBA/1 | Mammary gland adenocarcinoma |
|
Mammary gland |
0 - 90 |
|
DBA/2 | Mammary gland adenocarcinoma |
|
Mammary gland |
1 - 72 |
|
101 | Mammary gland tumor | Mammary gland |
low |
||
A/BrA | Mammary gland tumor | Mammary gland |
0 |
||
A/A | Mammary gland tumor | Mammary gland |
0 |
||
AL | Mammary gland tumor | Mammary gland |
very low |
||
BALB/c | Mammary gland tumor | Mammary gland |
3.0 - 30 |
||
BALB/cfC3H | Mammary gland tumor |
|
Mammary gland |
high - 100 |
|
BDP | Mammary gland tumor | Mammary gland |
moderate |
||
BL | Mammary gland tumor | Mammary gland |
low |
||
BLRB | Mammary gland tumor | Mammary gland |
95 |
||
BT/Os | Mammary gland tumor | Mammary gland |
70 |
||
C | Mammary gland tumor | Mammary gland |
moderate |
||
C3H | Mammary gland tumor |
|
Mammary gland |
90 - 100 |
|
C3H/Bi | Mammary gland tumor |
|
Mammary gland |
83 |
|
C3H/He | Mammary gland tumor |
|
Mammary gland |
90 |
|
C3H/He-Avy | Mammary gland tumor |
|
Mammary gland |
100 |
|
C3H/He-AvyfC57BL/He | Mammary gland tumor | Mammary gland |
90 |
||
C3HfC57BL | Mammary gland tumor | Mammary gland |
40 |
||
C3Hf | Mammary gland tumor | Mammary gland |
37 |
||
C3H | Mammary gland tumor | Mammary gland |
21.0 - 36.0 |
||
C3HA | Mammary gland tumor | Mammary gland |
30 |
||
C3HeB/De | Mammary gland tumor | Mammary gland |
4 - 74 |
||
C57BL | Mammary gland tumor | Mammary gland |
0 - 1 |
||
CBA | Mammary gland tumor | Mammary gland |
0 - 33 |
||
CBRB | Mammary gland tumor | Mammary gland |
50 |
||
CC57BR | Mammary gland tumor | Mammary gland |
0 |
||
CC57BR | Mammary gland tumor |
|
Mammary gland |
60 |
|
CC57W | Mammary gland tumor | Mammary gland |
0 |
||
CC57W | Mammary gland tumor |
|
Mammary gland |
55 |
|
DA/Hu | Mammary gland tumor | Mammary gland |
low |
||
DBA | Mammary gland tumor |
|
Mammary gland |
high |
|
DBA/2 | Mammary gland tumor | Mammary gland |
0 - 31 |
||
DD | Mammary gland tumor | Mammary gland |
84 |
||
DD/HefC57BL/He | Mammary gland tumor | Mammary gland |
4 |
||
DD/HefC3H/He | Mammary gland tumor |
|
Mammary gland |
91 |
|
DDD | Mammary gland tumor |
|
Mammary gland |
8 - 14 |
|
DSD | Mammary gland tumor | Mammary gland |
observed |
||
FM | Mammary gland tumor | Mammary gland |
high |
||
GRS | Mammary gland tumor |
|
Mammary gland |
high |
|
GRS | Mammary gland tumor |
|
Mammary gland |
observed |
|
IF | Mammary gland tumor | Mammary gland |
0 |
||
LIS | Mammary gland tumor | Mammary gland |
low |
||
LP | Mammary gland tumor | Mammary gland |
3 - 14 |
||
LTS | Mammary gland tumor | Mammary gland |
high |
||
MA | Mammary gland tumor | Mammary gland |
0 |
||
MA | Mammary gland tumor |
|
Mammary gland |
high |
|
MAS | Mammary gland tumor | Mammary gland |
low |
||
MAS | Mammary gland tumor |
|
Mammary gland |
observed |
|
NLC | Mammary gland tumor | Mammary gland |
15 - 60 |
||
NZY | Mammary gland tumor | Mammary gland |
high |
||
NZYfNZC/Bu | Mammary gland tumor | Mammary gland |
observed |
||
O20 | Mammary gland tumor |
|
Mammary gland |
observed |
|
O20 | Mammary gland tumor | Mammary gland |
0 - 13 |
||
PBA | Mammary gland tumor | Mammary gland |
74 |
||
PET | Mammary gland tumor | Mammary gland |
observed |
||
PM | Mammary gland tumor | Mammary gland |
high |
||
RIII | Mammary gland tumor |
|
Mammary gland |
70 - 96 |
|
RW | Mammary gland tumor | Mammary gland |
41 - 74 |
||
SHN | Mammary gland tumor | Mammary gland |
90.0 - 100.0 |
||
SLN | Mammary gland tumor | Mammary gland |
9.0 - 60.0 |
||
STS | Mammary gland tumor | Mammary gland |
0 |
||
SWR | Mammary gland tumor | Mammary gland |
7.0 - 30 |
||
T739 | Mammary gland tumor | Mammary gland |
3.4 |
||
TA2 | Mammary gland tumor | Mammary gland |
41 - 81 |
||
TM | Mammary gland tumor | Mammary gland |
low |
||
XVII | Mammary gland tumor | Mammary gland |
0 - 1.3 |
||
129 | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
1 - 2 |
||
C3HA | Mesodermal cell/mesoblast sarcoma |
|
Uterus |
0 |
|
C3HA | Mesodermal cell/mesoblast sarcoma |
|
Uterus |
observed |
|
B10.BR | Mesodermal cell/mesoblast sarcoma |
|
Mesodermal cell/mesoblast |
observed |
|
C57BL/6 | Mesodermal cell/mesoblast sarcoma |
|
Mesodermal cell/mesoblast |
observed |
|
C58 | Mesodermal cell/mesoblast sarcoma |
|
Mesodermal cell/mesoblast |
observed |
|
LP | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
6 - 7 |
||
BALB/cJ | Muscle - Striated - Skeletal rhabdomyosarcoma | Muscle - Striated - Skeletal |
sporadic |
||
A/J | Myoepithelial cell myoepithelioma | Myoepithelial cell |
sporadic |
||
A/HeJ | Myoepithelial cell myoepithelioma | Myoepithelial cell |
sporadic |
||
BALB/cByJ | Myoepithelial cell myoepithelioma | Myoepithelial cell |
sporadic |
||
BALB/cJ | Myoepithelial cell myoepithelioma | Myoepithelial cell |
sporadic |
||
LLC.A/Ckc | Myoepithelial cell myoepithelioma | Myoepithelial cell |
sporadic |
||
NOD | Myoepithelial cell myoepithelioma | Myoepithelial cell |
sporadic |
||
TM | Nerve tumor | CNS - Brain |
11 |
||
LT | Ovary - Germ cell teratoma | Ovary - Germ cell |
50 |
||
LT | Ovary - Germ cell teratoma |
|
Ovary - Germ cell |
50 |
|
CE | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
observed |
||
NZC | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
high |
||
NZO | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
low |
||
(SWR/Bm x SWXJ9/Bm)F1 | Ovary - Granulosa cell tumor | Ovary - Granulosa cell |
10.0 - 25.0 |
||
C3H | Ovary cyst | Ovary |
13.0 - 26.0 |
||
CE | Ovary tumor | Ovary |
34 - high |
||
FVB | Ovary tumor | Ovary |
observed |
||
RIII | Ovary tumor | Ovary |
50 - 60 |
||
C57BL | Pituitary gland adenoma |
|
Pituitary gland |
high |
|
NZY | Pituitary gland adenoma | Pituitary gland |
high |
||
NZYfNZC/Bu | Pituitary gland adenoma | Pituitary gland |
high |
||
C57BR/cd | Pituitary gland tumor | Pituitary gland |
33 |
||
C57L | Pituitary gland tumor | Pituitary gland |
33 |
||
FVB | Pituitary gland tumor | Pituitary gland |
observed |
||
NZB | Pituitary gland tumor | Pituitary gland |
25 |
||
BALB/c | Reticular cell reticulum cell neoplasm | Reticular cell |
3 - 23 |
||
L2 | Reticular cell reticulum cell neoplasm | Reticular cell |
50 |
||
HR/De Hrhr | Skin papilloma | Skin |
3.0 - 9.0 |
||
BALB/c | Skin tumor |
|
Skin |
observed |
|
SEN | Skin tumor |
|
Skin |
observed |
|
SSIN | Skin tumor |
|
Skin |
high |
|
TM | Stomach - Glandular - Pyloric antrum tumor | Stomach - Glandular - Pyloric antrum |
13 |
||
BT/Os | Stomach tumor |
|
Stomach |
high |
|
129T1/Sv-Oca2+ Tyrc-ch Dnd1Ter/J | Testis - Germ cell teratoma | Testis - Germ cell |
30 |
||
129 | Testis - Germ cell teratoma | Testis - Germ cell |
1 |
||
A | Testis - Leydig cell (Interstitial cell) tumor |
|
Testis - Leydig cell (Interstitial cell) |
observed |
|
BALB/c | Testis - Leydig cell (Interstitial cell) tumor |
|
Testis - Leydig cell (Interstitial cell) |
high |
|
C57BL/Ka | Testis - Leydig cell (Interstitial cell) tumor | Testis - Leydig cell (Interstitial cell) |
13 |
||
C57BL/Ka | Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell |
9 |
||
BALB/c | Uterus tumor |
|
Uterus |
observed |
|
C57BL | Uterus tumor |
|
Uterus |
observed |
|
BALB/c | (Unspecified organ) angioma | (Unspecified organ) |
6 |
||
RW | (Unspecified organ) lymphohematopoietic neoplasm | (Unspecified organ) |
41.0 - 49.0 |
||
I | (Unspecified organ) papilloma |
|
(Unspecified organ) |
observed |
|
BALB/c | (Unspecified organ) reticuloendothelial neoplasm | (Unspecified organ) |
11.0 - 20.0 |
||
DW | (Unspecified organ) reticulum cell sarcoma | (Unspecified organ) |
45.0 - 61.0 |
||
RF | (Unspecified organ) reticulum cell sarcoma | (Unspecified organ) |
52 |
||
RFM | (Unspecified organ) reticulum cell sarcoma | (Unspecified organ) |
57 - 70 |
||
SJL | (Unspecified organ) reticulum cell sarcoma | (Unspecified organ) |
90 |
||
WHT | (Unspecified organ) squamous cell carcinoma | (Unspecified organ) |
observed |
||
129 | (Unspecified organ) tumor | (Unspecified organ) |
7 - 21 |
||
BUA | (Unspecified organ) tumor | (Unspecified organ) |
0 |
||
C17/Icrc | (Unspecified organ) tumor | (Unspecified organ) |
low |
||
DMC | (Unspecified organ) tumor | (Unspecified organ) |
0 |
||
DW Pou1f1dw/+ | (Unspecified organ) tumor | (Unspecified organ) |
sporadic |
||
DW | (Unspecified organ) tumor | (Unspecified organ) |
high |
||
FVB | (Unspecified organ) tumor | (Unspecified organ) |
55 - 66 |
||
IOR | (Unspecified organ) tumor | (Unspecified organ) |
32 |
||
NH | (Unspecified organ) tumor | (Unspecified organ) |
low |
||
SM/J | (Unspecified organ) tumor | (Unspecified organ) |
very low |
||
SSIN | (Unspecified organ) tumor | (Unspecified organ) |
low |
||
ST/b | (Unspecified organ) tumor | (Unspecified organ) |
low |
||
X | (Unspecified organ) tumor | (Unspecified organ) |
0 |
||
XLII | (Unspecified organ) tumor | (Unspecified organ) |
very low |
||
YBR | (Unspecified organ) tumor | (Unspecified organ) |
low |
||
C3H/BiDa | (Unspecified organ) tumor |
|
(Unspecified organ) |
observed |
|
129 | (Unspecified organ) tumor - benign | (Unspecified organ) |
2 - 3 |